Hereditary Breast Cancer Panel
A focused 13-gene panel for evaluating hereditary breast cancer predisposition, powered by the Helix Exome+® platform for superior coverage of clinically relevant regions.
6-21 days
≤ 5 days
Panel Description
Hereditary predisposition to breast cancer refers to the increased likelihood of developing adult-onset breast cancer due to genetic factors that are passed down in families. The most well-known genes are BRCA1 and BRCA2, although there are others, including the genes on this panel. Individuals with a pathogenic variant may also have an increased risk of other cancers such as ovarian and prostate, depending on the affected gene.
This panel evaluates 13 genes that have an established primary association with hereditary predisposition to breast cancer.
Have Questions?
Our team is available Monday through Friday, 9am-5pm Pacific Time.
Indications for Testing
A personal and/or family history suggestive of a hereditary form of breast cancer predisposition.
Methodology
This test utilizes next-generation sequencing to detect single nucleotide variants, insertions and deletions up to 20 bp, and copy number variants in genes associated with hereditary forms of breast cancer.
Technical Specifications
> 99%
> 99%
> 99%
> 99%
> 90%
BRCA1: sequencing analysis extends to CDS +/-20 bp; BRCA2: analysis includes detection of c.156_157insAlu and sequencing analysis extends to CDS +/-20 bp; PTEN: analysis includes CNV of the promoter; ...
GRCh38
Genes Tested
Showing 13 of 13 genes in this panel